Benitec Biopharma Inc
NASDAQ:BNTC
Cash Flow Statement
Cash Flow Statement
Benitec Biopharma Inc
| Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||||
| Net Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
(22)
|
(27)
|
(34)
|
(26)
|
(38)
|
(42)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
17
|
22
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
17
|
22
|
|
| Change in Working Capital |
(0)
|
4
|
0
|
(1)
|
(4)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(11)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(18)
|
(19)
|
(18)
|
(19)
|
(18)
|
(4)
|
1
|
6
|
11
|
4
|
(3)
|
(2)
|
|
| Cash from Operating Activities |
2
N/A
|
9
+407%
|
1
-84%
|
(1)
N/A
|
5
N/A
|
2
-67%
|
1
-50%
|
(8)
N/A
|
(9)
-24%
|
(10)
-3%
|
(11)
-13%
|
(13)
-18%
|
(15)
-15%
|
(15)
0%
|
(16)
-10%
|
(16)
+2%
|
(16)
+1%
|
(18)
-16%
|
(19)
-3%
|
(18)
+4%
|
(19)
-3%
|
(18)
+3%
|
(20)
-12%
|
(19)
+4%
|
(19)
0%
|
(22)
-12%
|
(19)
+14%
|
(24)
-26%
|
(22)
+5%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+600%
|
0
+100%
|
0
-57%
|
0
N/A
|
(0)
N/A
|
(0)
-189%
|
(0)
-38%
|
(0)
-3%
|
(0)
+41%
|
(0)
+77%
|
0
N/A
|
0
+8%
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
+91%
|
(0)
N/A
|
(0)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
(14)
|
(8)
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
11
|
12
|
26
|
0
|
14
|
14
|
0
|
18
|
18
|
18
|
18
|
31
|
31
|
31
|
74
|
65
|
83
|
113
|
73
|
51
|
|
| Other |
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(2)
|
(2)
|
(3)
|
0
|
(2)
|
(2)
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(6)
|
(3)
|
(3)
|
(5)
|
(2)
|
0
|
|
| Cash from Financing Activities |
(13)
N/A
|
(7)
+47%
|
0
N/A
|
(6)
N/A
|
2
N/A
|
2
N/A
|
2
N/A
|
2
N/A
|
0
N/A
|
10
N/A
|
10
N/A
|
23
+129%
|
0
N/A
|
13
N/A
|
13
N/A
|
0
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
28
+74%
|
28
+0%
|
28
N/A
|
68
+143%
|
62
-9%
|
80
+29%
|
108
+36%
|
70
-35%
|
49
-31%
|
|
| Change in Cash | ||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(2)
|
(0)
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(11)
N/A
|
2
N/A
|
2
-36%
|
(6)
N/A
|
6
N/A
|
3
-45%
|
1
-70%
|
(6)
N/A
|
(9)
-55%
|
0
N/A
|
1
+176%
|
10
+1 619%
|
8
-17%
|
(2)
N/A
|
(3)
-101%
|
(16)
-369%
|
1
N/A
|
(2)
N/A
|
(2)
-16%
|
(2)
+24%
|
9
N/A
|
10
+5%
|
8
-23%
|
48
+538%
|
42
-13%
|
58
+38%
|
89
+54%
|
47
-48%
|
27
-43%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||||
| Free Cash Flow |
2
N/A
|
9
+401%
|
1
-84%
|
(1)
N/A
|
5
N/A
|
2
-67%
|
1
-51%
|
(8)
N/A
|
(10)
-26%
|
(10)
-4%
|
(11)
-12%
|
(13)
-16%
|
(15)
-13%
|
(15)
+1%
|
(16)
-10%
|
(16)
+1%
|
(16)
+2%
|
(18)
-16%
|
(19)
-3%
|
(18)
+4%
|
(19)
-3%
|
(18)
+3%
|
(20)
-13%
|
(20)
+4%
|
(19)
+1%
|
(22)
-13%
|
(19)
+15%
|
(24)
-26%
|
(22)
+5%
|
|